HIGH

W L Gore & Associates Recalls Vascular Grafts Over Delamination Risk

W L Gore & Associates recalled over 52,000 vascular grafts on August 26, 2025, due to reports of delamination. The defect can lead to severe complications such as bleeding or cannulation difficulties. Affected products include multiple model numbers, which were distributed across the United States and internationally.

Quick Facts at a Glance

Recall Date
August 26, 2025
Hazard Level
HIGH
Brand
W L Gore & Associates
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
Nationwide (50 states)
At-Risk Groups
GENERAL

Hazard Information

Reports of vascular graft delamination, which may lead to reduced access flow; cannulation difficulties; bleeding or bruising; and harms related to reintervention procedures, so Instructions for Use will be updated to modify existing warning to 1) further clarify techniques that may contribute to the risk of delamination, 2) Addition of delamination to device-related adverse event section.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact W L Gore & Associates, Inc. or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall affects GORE ACUSEAL Vascular Grafts with reference numbers including ECH050020J, ECH050050W, and ECH060040. These devices were sold to healthcare providers and facilities in the U.S. and multiple countries including Canada, Germany, and the United Kingdom.

The Hazard

Reports indicate that delamination of the vascular grafts may result in reduced access flow, bleeding, and complications requiring further medical intervention. The FDA classified this recall as Class II, indicating a potential for serious adverse health consequences.

Reported Incidents

There have been no specific incident or injury counts reported in the recall notice. However, the potential risks include serious complications related to cannulation difficulties and the need for reintervention.

What to Do

Patients and healthcare providers should immediately stop using the device. Follow the recall instructions from the manufacturer and contact W L Gore & Associates, Inc. for further guidance.

Contact Information

For assistance, contact W L Gore & Associates, Inc. directly. Visit their website or refer to the recall link for more information.

Key Facts

  • Recall date: August 26, 2025
  • Report date: October 8, 2025
  • Quantity recalled: 52,306 units
  • Affected regions: US and multiple countries
  • Classification: Class II

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
BURNOTHER

Product Details

Model Numbers
REF/UDI-DI: ECH050020J/04993024010758
ECH050020W/00733132635450
ECH050050J/04993024010772
ECH050050W/00733132635474
ECH060010A/00733132622573
+12 more
Affected States
Nationwide
Report Date
October 8, 2025
Source Agency
FDA - Medical Devices
Recall Status
ACTIVE

Related Recalls

HIGH

Novo Nordisk Recalls Wegovy Injection Due to Contamination Risk

Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.

Wegovy
Presence of
Read more
HIGH

Zydus Pharmaceuticals Recalls TraZODONE Tablets Over Defects

Zydus Pharmaceuticals recalled over 2,100 bottles of TraZODONE Hydrochloride Tablets on December 19, 2025. Some tablets have surface dents that may affect medication integrity. Consumers should stop using the product immediately and seek guidance from healthcare providers.

Zydus Pharmaceuticals
Failed Tablet/Capsule
Read more
HIGH

Merck Recalls Noxafil Oral Suspension Due to Metal Contamination

Merck Sharp & Dohme LLC recalled 845 kits of Noxafil Powdermix on December 12, 2025. The recall follows the discovery of potential metal particulates in the product. Consumers should stop using the medication immediately and contact their healthcare provider for further guidance.

NOXAFIL
Presence of
Read more
HIGH

Merck Emend Recalled Due to Potential Metal Contamination

Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.

EMEND
Presence of
Read more
HIGH

Beaver-Visitec Recalls Laser and Endoscopy System Over Safety Hazard

Beaver-Visitec International recalled five units of the OME6000U Laser and Endoscopy System on December 5, 2025. The recall stems from a manufacturing deviation where ferrites required for the USB cable were not installed. This omission poses a high electrical hazard risk to patients and healthcare providers.

Beaver-Visitec International
Manufacturing deviation
Read more